Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
396 studies found for:    "Diabetic Retinopathy"
Show Display Options
RSS Create an RSS feed from your search for:
"Diabetic Retinopathy"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: COLIRIOBCN070660;   Drug: Placebo;   Drug: Brimonidine
2 Completed Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Octreotide Acetate in Microspheres 20 mg;   Drug: Octreotide Acetate in Microspheres;   Drug: Placebo
3 Completed Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Octreotide Acetate in Microspheres;   Drug: Placebo
4 Unknown  Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
Condition: Diabetic Retinopathy
Interventions: Drug: ranibizumab and vitrectomy;   Procedure: vitrectomy without preoperative ranibizumab
5 Completed A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Qi ming granula;   Drug: Placebo Comparator
6 Completed Severe Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Procedure: vitrectomy;   Procedure: panretinalphotocoagulation
7 Not yet recruiting A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
8 Terminated Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Octreotide acetate in microspheres
9 Completed Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Vitrectomy for proliferative diabetic retinopathy
10 Completed Topical Application of Latanoprost in Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Latanoprost
11 Terminated Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Octreotide acetate in microspheres
12 Unknown  Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser
Condition: Diabetic Retinopathy
Intervention: Procedure: Panretinal photocoagulation
13 Not yet recruiting Diabetic Retinopathy Screening in Private Practice
Condition: Diabetic Retinopathy
Interventions: Other: Free screening group;   Other: Pay screening group ($150);   Other: Pay screening group ($300)
14 Unknown  Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Macugen ® (pegaptanib sodium)
15 Active, not recruiting OCT Biomarkers for Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention:
16 Unknown  Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: intravitreal injection of bevacizumab;   Procedure: panretinal photocoagulation
17 Completed Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: doxycycline monohydrate;   Drug: Placebo
18 Completed The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong
Condition: Diabetic Retinopathy
Interventions: Other: charging a co-payment for Diabetic Retinopathy screening;   Other: free screening without charging a co-payment
19 Completed Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Vitrectomy
20 Completed Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.